Publications by Medical Specialty - Oncology

These publications were authored or co-authored by Quest Diagnostics staff.

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Authors: Kaufman HW, Chen Z, Niles J, Fesko Y
JAMA Network Open. 2020;3(8):e2017267. doi:10.1001/jamanetworkopen.2020.17267

Specialties: Infectious Disease, Oncology

Read the Key Summary (Download PDF)

Sporadic Oncocytic Tumors with Features Intermediate between Oncocytoma and Chromophobe Renal Cell Carcinoma: Comprehensive Clinico-Pathological and Genomic Profiling

Authors: Yajuan J Liu, Cigdem Ussakli, Tatjana Antic, Yuhua Liu, Yu Wu, Lawrence True, Maria S Tretiakova
Hum Pathol. 2020 Jul 13;S0046-8177(20)30126-X. doi: 10.1016/j.humpath.2020.07.003. Online ahead of print.

Specialties: Genetics, Oncology, Pathology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States

Authors: Kaufman HW, Alagia DP, Chen Z, Onisko A, Austin RM.
Am J Clin Pathol. 2020 Jul 8;aqaa074. doi: 10.1093/ajcp/aqaa074. Online ahead of print.

Specialties: Oncology, Women's Health/OB/GYN

Next-Generation Sequencing in High-Sensitive Detection of Mutations in Tumors: Challenges, Advances and Applications

Authors: Singh RR
J Mol Diagn. 2020 May 29:S1525-1578(20)30330-5. doi: 10.1016/j.jmoldx.2020.04.213.

Specialties: Genetics, Oncology

Xanthogranulomatous Epithelial Tumor: Report of 6 Cases of a Novel, Potentially Deceptive Lesion With a Predilection for Young Women

Authors: Fritchie KJ, Torres-Mora J, Inwards C, Thway K, Vaiyapuri S, Jackson R, Minn K, Halling K, Arndt C, Houdek MT, Wenger DE, Curry R, Thirumala S, Fisher C, Davila J, Folpe AL.
Mod Pathol. 2020 May 15. doi: 10.1038/s41379-020-0562-8. Online ahead of print.

Specialties: Dermatology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.

Authors: Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M; International Immuno-Oncology Biomarker Working Group.
J Pathol. 2020 Apr;250:667-684. doi: 10.1002/path.5406. Epub 2020 Apr 9.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.

Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.

Specialties: Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.

Salivary ghost cell carcinoma: case report and proposal of a new entity.

Authors: Ihrler S, Mollenhauer M, Weitmayr B, Haas CJ.
Virchows Arch. 2020 Mar;476(3):465-468.

Specialties: Dermatology, Oncology

Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.

Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing

Authors: Rosenthal SH, Sun W, Zhang K, Liu Y, Nguyen Q, Gerasimova A, Nery C, Cheng L, Castonguay C, Hiller E, Li J, Elzinga C, Wolfson D, Smolgovsky A, Chen R, Buller-Burckle A, Catanese J, Grupe A, Lacbawan F,Owen R
BioMed Res Int. 2020, https://doi.org/10.1155/2020/3289023 [Epub ahead of print]

Specialties: Oncology

Read the Key Summary (Download PDF)